tiprankstipranks
Trending News
More News >
AstraZeneca plc (CH:ZEG)
:ZEG
Switzerland Market

AstraZeneca (ZEG) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

ZEG Analyst Ratings

Moderate Buy
14Ratings
10 Buy
4 Hold
0 Sell
Based on 14 analysts giving stock ratings to
AstraZeneca
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZEG Stock 12 Month Forecast

Average Price Target

CHF147.01
▲(20.92% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for AstraZeneca in the last 3 months. The average price target is CHF147.01 with a high forecast of CHF188.72 and a low forecast of CHF119.59. The average price target represents a 20.92% change from the last price of CHF121.57.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"118":"CHF118","189":"CHF189","135.75":"CHF135.8","153.5":"CHF153.5","171.25":"CHF171.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":188.7184,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF188.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":147.008342,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF147.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":119.5948,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF119.59</span>\n  </div></div>","useHTML":true}}],"tickPositions":[118,135.75,153.5,171.25,189],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,121.572,126.73710769230769,131.90221538461537,137.0673230769231,142.23243076923077,147.39753846153846,152.56264615384615,157.72775384615386,162.89286153846155,168.05796923076923,173.22307692307692,178.3881846153846,183.5532923076923,{"y":188.7184,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,121.572,123.5286416923077,125.48528338461539,127.44192507692308,129.39856676923077,131.35520846153847,133.31185015384617,135.26849184615384,137.22513353846153,139.18177523076923,141.13841692307693,143.0950586153846,145.0517003076923,{"y":147.008342,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,121.572,121.41990769230769,121.26781538461539,121.11572307692308,120.96363076923078,120.81153846153846,120.65944615384616,120.50735384615385,120.35526153846155,120.20316923076923,120.05107692307693,119.89898461538462,119.74689230769232,{"y":119.5948,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":121.572,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.572,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF188.72Average Price TargetCHF147.01Lowest Price TargetCHF119.59
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Berenberg Bank
CHF154.35
Buy
26.96%
Upside
Reiterated
03/26/25
Berenberg Bank Sticks to Their Buy Rating for AstraZeneca (AZN)
Morgan Stanley
CHF159.86
Buy
31.50%
Upside
Reiterated
03/10/25
AstraZeneca's Promising Pipeline and Market Potential Drive Buy Rating Amid Positive Competitor Data
DZ BANK AG
Hold
Reiterated
02/07/25
AstraZeneca (AZN) Receives a Hold from DZ BANK AG
Kepler Capital
CHF124.58
Hold
2.48%
Upside
Reiterated
02/06/25
Guggenheim
CHF144.43
Buy
18.80%
Upside
Reiterated
01/29/25
Guggenheim Sticks to Their Buy Rating for AstraZeneca (AZN)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Berenberg Bank
CHF154.35
Buy
26.96%
Upside
Reiterated
03/26/25
Berenberg Bank Sticks to Their Buy Rating for AstraZeneca (AZN)
Morgan Stanley
CHF159.86
Buy
31.50%
Upside
Reiterated
03/10/25
AstraZeneca's Promising Pipeline and Market Potential Drive Buy Rating Amid Positive Competitor Data
DZ BANK AG
Hold
Reiterated
02/07/25
AstraZeneca (AZN) Receives a Hold from DZ BANK AG
Kepler Capital
CHF124.58
Hold
2.48%
Upside
Reiterated
02/06/25
Guggenheim
CHF144.43
Buy
18.80%
Upside
Reiterated
01/29/25
Guggenheim Sticks to Their Buy Rating for AstraZeneca (AZN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AstraZeneca

Which Analyst Should I Follow If I Want to Buy CH:ZEG and Sell After:
1 Month
xxx
Success Rate
22/42 ratings generated profit
52%
Average Return
+1.51%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.38% of your transactions generating a profit, with an average return of +1.51% per trade.
3 Months
xxx
Success Rate
24/42 ratings generated profit
57%
Average Return
+1.75%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +1.75% per trade.
1 Year
Success Rate
26/31 ratings generated profit
84%
Average Return
+13.57%
reiterated a buy rating 5 days ago
Copying Matthew Weston's trades and holding each position for 1 Year would result in 83.87% of your transactions generating a profit, with an average return of +13.57% per trade.
2 Years
xxx
Success Rate
26/31 ratings generated profit
84%
Average Return
+21.98%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 83.87% of your transactions generating a profit, with an average return of +21.98% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZEG Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
1
1
0
0
0
Buy
21
29
31
43
46
Hold
10
11
12
10
8
Sell
0
0
0
0
0
Strong Sell
3
3
0
0
0
total
35
44
43
53
54
In the current month, ZEG has received 46 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ZEG average Analyst price target in the past 3 months is 147.01.
Each month's total comprises the sum of three months' worth of ratings.

ZEG Financial Forecast

ZEG Earnings Forecast

Next quarter’s earnings estimate for ZEG is CHF1.82 with a range of CHF1.50 to CHF2.06. The previous quarter’s EPS was CHF2.05. ZEG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.51% of the time in the same period. In the last calendar year ZEG has Outperformed its overall industry.
Next quarter’s earnings estimate for ZEG is CHF1.82 with a range of CHF1.50 to CHF2.06. The previous quarter’s EPS was CHF2.05. ZEG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.51% of the time in the same period. In the last calendar year ZEG has Outperformed its overall industry.

ZEG Sales Forecast

Next quarter’s sales forecast for ZEG is CHF11.58B with a range of CHF11.23B to CHF12.19B. The previous quarter’s sales results were CHF11.91B. ZEG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.38% of the time in the same period. In the last calendar year ZEG has Outperformed its overall industry.
Next quarter’s sales forecast for ZEG is CHF11.58B with a range of CHF11.23B to CHF12.19B. The previous quarter’s sales results were CHF11.91B. ZEG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.38% of the time in the same period. In the last calendar year ZEG has Outperformed its overall industry.

ZEG Stock Forecast FAQ

What is CH:ZEG’s average 12-month price target, according to analysts?
Based on analyst ratings, AstraZeneca plc’s 12-month average price target is 147.01.
    What is CH:ZEG’s upside potential, based on the analysts’ average price target?
    AstraZeneca plc has 20.92% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AstraZeneca plc a Buy, Sell or Hold?
          AstraZeneca plc has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
            What is AstraZeneca plc’s share price target?
            The average share price target for AstraZeneca plc is 147.01. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF188.72 ,and the lowest forecast is CHF119.59. The average share price target represents 20.92% Increase from the current price of CHF121.57.
              What do analysts say about AstraZeneca plc?
              AstraZeneca plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of AstraZeneca plc?
                To buy shares of CH:ZEG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis